Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

NPPA sets ceiling prices of 14 formulations including Diabetes FDCs, details

Ruchika Sharma12 Jan 2021 6:40 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority, the pharma price regulator has fixed the price of 14...

Russian COVID vaccine: Sputnik V meets primary safety endpoint in Phase 2 Clinical Trial in India

Ruchika Sharma12 Jan 2021 12:32 PM IST

The safety data has been submitted to the Drugs Controller General of India (DCGI) for review and approval to continue phase 3 clinical trials.

Boehringer Ingelheim finds Country MD for India in Vani Manja

Ruchika Sharma12 Jan 2021 11:30 AM IST

New Delhi: Drug firm Boehringer Ingelheim on Monday said it has appointed Vani Manja as country Managing Director for India, effective January 1,...

Dr. Reddy's Labs unveils generic Uloric Tablets in US

Ruchika Sharma12 Jan 2021 11:00 AM IST

Hyderabad & Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the launch of Febuxostat Tablets.The product is a therapeutic...

COVID-19 vaccine immunity to stay at least a year: Moderna

Ruchika Sharma12 Jan 2021 10:30 AM IST

The company's vaccine,mRNA-1273, uses synthetic mRNA to mimic the surface of the coronavirus and teach the immune system to recognize and neutralize...

Indian Govt wants Serum Institute of India to bring down AstraZeneca covid vaccine price: Sources

Ruchika Sharma11 Jan 2021 4:25 PM IST

Senior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot, one of...

COVID-19 vaccine main candidates - Where they stand

Ruchika Sharma11 Jan 2021 1:23 PM IST

New Delhi: Almost a year into the Covid-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several...

Cipla, Strides Pharma recall drugs in US

Ruchika Sharma11 Jan 2021 11:41 AM IST

The USFDA cited "cross-contamination with other products" as the reason for Cipla recalling the product.

Serum Institute of India Covishield transportation to begin soon

Ruchika Sharma11 Jan 2021 11:00 AM IST

Pune: With the COVID-19 vaccination drive in India set to rollout on January 16, the transportation of Covishield vaccine from the Serum Institute of...

NGO working for gas victims opposes Bharat Biotech Covaxin trial in Bhopal

Ruchika Sharma11 Jan 2021 9:15 AM IST

"One gas victim has already died within 10 days of getting the trail shot and many continue to have health complaints of serious nature, "Bee alleged.

Violations of Drugs and Cosmetics Act: License of 18 medical stores suspended in Jnk

Ruchika Sharma11 Jan 2021 9:00 AM IST

The reasons for suspension ranged from Non maintenance of Sales records, Impersonation, Unhygienic/Insanitary Conditions, Improper storage conditions...

India to continue export of medicines, vaccines as firms ramp up production: PM Modi

Ruchika Sharma10 Jan 2021 10:30 AM IST

New Delhi: Indian Prime Minister Narendra Modi said on Saturday the nation would continue to export medicines, including vaccines, as companies have...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok